open access

Vol 12, No 3 (2011): Practical Diabetology
Review articles (submitted)
Published online: 2011-10-10
Get Citation

The role the sulphonylurea drugs in therapy of type 2 diabetes. Whether all derivates from this group equally affect on mortality from general causes and cardiovascular risk?

Władysław Grzeszczak
Diabetologia Praktyczna 2011;12(3):79-89.

open access

Vol 12, No 3 (2011): Practical Diabetology
Review articles (submitted)
Published online: 2011-10-10

Abstract

Lowering the blood glucose level has a key importance in the prevention and the inhibition of progression of late diabetic complications (macroand microvascular). This purpose is being accomplished through the change of a lifestyle and the use of antidiabetic drugs. The sulphonylurea are one of important groups of drugs in this regard. At the present paper I presented: mechanism of action of the sulphonylurea drugs, preparats of the sulphonylurea drugs available on the Polish market and new findings about the differences of the sulphonylurea action on the risk of the death for general reasons and to the cardiovascular risk. I showed in presented findings, that out of all derivatives of the sulphonylurea only gliclazyd in the significant way influenced for lowering the risk of deaths for general reasons and for cardiovascular reasons. After describing examinations a suggestion arose, that from amongst derivatives of the sulphonylurea gliclazyd should be a medicine by choice.
(Diabet. Prakt. 2011; 12, 3: 79–89)

Abstract

Lowering the blood glucose level has a key importance in the prevention and the inhibition of progression of late diabetic complications (macroand microvascular). This purpose is being accomplished through the change of a lifestyle and the use of antidiabetic drugs. The sulphonylurea are one of important groups of drugs in this regard. At the present paper I presented: mechanism of action of the sulphonylurea drugs, preparats of the sulphonylurea drugs available on the Polish market and new findings about the differences of the sulphonylurea action on the risk of the death for general reasons and to the cardiovascular risk. I showed in presented findings, that out of all derivatives of the sulphonylurea only gliclazyd in the significant way influenced for lowering the risk of deaths for general reasons and for cardiovascular reasons. After describing examinations a suggestion arose, that from amongst derivatives of the sulphonylurea gliclazyd should be a medicine by choice.
(Diabet. Prakt. 2011; 12, 3: 79–89)
Get Citation

Keywords

type 2 diabetes; the sulphonylurea derivates; gliclazyd; mortality from general causes; cardiovascular risk

About this article
Title

The role the sulphonylurea drugs in therapy of type 2 diabetes. Whether all derivates from this group equally affect on mortality from general causes and cardiovascular risk?

Journal

Clinical Diabetology

Issue

Vol 12, No 3 (2011): Practical Diabetology

Pages

79-89

Published online

2011-10-10

Bibliographic record

Diabetologia Praktyczna 2011;12(3):79-89.

Keywords

type 2 diabetes
the sulphonylurea derivates
gliclazyd
mortality from general causes
cardiovascular risk

Authors

Władysław Grzeszczak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl